Delivery Order SPE2DB24D2003-SPE2DB25FXHA9

Award Date 4/23/25
Potential Completion Date 4/24/25
Potential Value $5.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Nurtec ODT 75 mg tablets, a medication used to treat migraines. The contract has a ceiling value of $9,598.64 and a completion date of April 22, 2025. It is a firm fixed-price contract, and there is no set-aside designation, indicating open competition. AmerisourceBergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Nurtec ODT 75 mg tablets, a medication used to treat migraines. The delivery order has a ceiling value of $19,742.28 and a period of performance through April 11, 2025. This contract is not set aside and is considered an open competition award. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Nurtec ODT 75 mg tablets, a prescription medication used to treat migraines. The contract is a firm fixed-price delivery order with a ceiling value of $8,922.41 and a performance period ending on April 11, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Nurtec ODT 75 mg tablets, a medication used to treat migraines. The contract has a ceiling value of $24,999.31 and a period of performance ending on April 9, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Nurtec ODT 75 mg tablets, a medication used to treat migraines. The contract has a ceiling value of $16,015.13 and a period of performance through April 18, 2025. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition....
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Nurtec ODT 75 mg tablets, a medication used to treat migraines. The delivery order has a ceiling value of $22,736.38 and a period of performance ending on April 8, 2025. The contract is a firm fixed-price, non-set-aside vehicle, indicating open competition. AmerisourceBergen Drug Corp is a significant federal...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, one of the largest pharmaceutical distributors in the United States. The contract is for the supply of Nurtec ODT 75 mg tablets, a medication used for the treatment of migraines. The contract has a ceiling value of $22,217.22 and a performance period ending on August 29, 2024. This contract is not set aside for any specific business type....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of NURTEC ODT 75 MG TABLET 8S, a medication used to treat migraines. The contract has a ceiling value of $4,696.90 and a period of performance through March 29, 2024. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,110.24 firm fixed-price contract is for the delivery of Nurtec ODT 75 mg tablets, a medication used to treat migraines. The contract has an ultimate completion date of April 9, 2025 and is not set-aside. Amerisourcebergen Drug Corp is the prime contractor and this award is part of a larger $999,999,999.00...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $13,958.62. The order is for Nurtec ODT 75 mg tablets, a medication used to treat migraine. The contract has a firm fixed price and a completion date of June 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a...
  • SPE2DB24D2003
    Indefinite Delivery Contract
  • SPE2DB24D2003-SPE2DB25FXHA9
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Nurtec ODT 75 mg tablets, a prescription medication used to treat migraines. The contract has a ceiling value of $5,581.62 and a completion date of April 24, 2025. It is a firm-fixed-price contract, indicating a pre-determined price for the delivered goods. AmerisourceBergen Drug Corp is a large, for-profit corporation that serves as a critical supplier of medical and pharmaceutical products to federal agencies, particularly the DLA. The company holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract is not designated as a set-aside, meaning it was open to general competition.

Generated 7/23/25, 9:43 AM